| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |